SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biogen
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1686 75 0 BIIB
Emcee:  Harold Engstrom Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
661 wpckr: It's not quite that simple. It means that, certainly, BGEN and IDPscaram(o)uche-5/21/1998
660 Richard--please give us a brief explanation of how this effects Biogen. Thankswpckr-5/21/1998
659 To all: As I've tried to argue, the use patents for CD40L antagonists are scaram(o)uche-5/21/1998
658 Light volume. This is interesting. Harold Engstrom-5/20/1998
657 Something must be up...all the volume and advance was in the last 50 minutes. Tom DuBois-5/18/1998
656 I don't think so but the last suit was cleared so quickly perhaps the same wpckr-5/18/1998
655 Quite a pop today, anyone know why? This news release can't be the reason Wowzer-5/18/1998
654 Thank you, Harold. wpckr-5/15/1998
653 Biogen relies on Avonex, a recombinant beta interferon, for most of its revenueHarold Engstrom-5/15/1998
652 I am new to ownership of this stock. Did your post indicate that A-S is a compwpckr-5/14/1998
651 ARES-SERONO ANNOUNCES EUROPEAN APPROVAL OF REBIF FOR MULTIPLE SCLEROSIS RebifHarold Engstrom-5/8/1998
650 After the market... CAMBRIDGE, Mass., May 6 /PRNewswire/ -- Biogen, Inc. (NasHarold Engstrom-5/6/1998
649 Bruce...we agree. Where we crossed wires is in the length of time of our analyJonas Grumby-4/30/1998
648 Point & Figure RS signals last on average 2-2 1/2 years. The RS buy signalBwe-4/29/1998
647 You are correct Bruce..it is in the eye of the beholder. I was referring to NOJonas Grumby-4/29/1998
646 >>>Stanley..it is not JUST the lawsuit. Biogen in under-performing theBwe-4/29/1998
645 Stanley..it is not JUST the lawsuit. Biogen in under-performing the Nasdaq ANDJonas Grumby-4/28/1998
644 Hey DONT OVERREACT. This company may not even lose this lawsuit, since HirulogStanley Cowen-4/28/1998
643 ***BAD NEWS*** Biogen shareholder lawsuit heads to court quicken.excite.comJonas Grumby-4/26/1998
642 I believe Amgens Infergen is a tradename for consensus interferon CIFN. FurtheIRWIN JAMES FRANKEL-4/14/1998
641 Harold, do you know when the conference call transcript will be posted?Peter Singleton-4/13/1998
640 Stanley, thanks for posting your summary of the article in your local paper. IHarold Engstrom-4/13/1998
639 Local paper reported positive results from yearlong study at University of of MStanley Cowen-4/10/1998
638 Good point! Almost two percent of the first 4,000,000 posts here seem to have bMichelino-4/10/1998
637 <i>Once last question...why does this company get so little attention hermichael meyers-4/10/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News